Comprehensive analysis of vitamin D 3 impurities in oily drug products using supercritical fluid chromatography–mass spectrometry
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3670 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Hugues Jambo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Analytical Chemistry, CIRM, ScF-Santé hub, University of Liège (ULiège), Liège, Belgium. Hauptthemen laut MEDLINE: Chromatography, Supercritical Fluid, Drug Contamination, Limit of Detection, Cholecalciferol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Vitamin D 3 , an essential micronutrient, often requires supplementation via medicines or food supplements, which necessitate quality control (QC). This study presents the development of a method for detecting and quantifying seven impurities of vitamin D 3 in oily drug products using supercritical fluid chromatography–mass spectrometry (SFC‐MS). Targeted impurities include two esters of vitamin D 3 and five non‐esters including four that are isobaric to vitamin D 3 . Firstly, a screening study highlighted the Torus 1‐AA column and acetonitrile modifier as adequate for the separation, followed by optimization of the SFC conditions. Secondly, make‐up solvent composition and MS settings were optimized to reach high sensitivity. For both the separation and MS response, the screening design of experiments proved useful. Lastly, a fast saponification and liquid–liquid extraction method was developed, enabling efficient sample cleanup and impurities recovery from the complex oily matrix. The SFC‐MS method suitability was assessed in two validation studies. The first study employed the ICH Q2 guideline for impurity limit test to demonstrate method specificity and establish a limit of detection (LOD) and a limit of quantification (LOQ) at 0.2% and 0.5%, respectively, for ester impurities. The second study conducted a comprehensive quantitative assessment for three non‐ester impurities using a total error approach, determining method validity through accuracy profiles. The validated method exhibited reliable performance across impurity concentrations from 0.1% to 2.0%, with estimated LODs ranging from 2 to 7 ng/mL. This study further promotes SFC‐MS as a valuable, versatile, and green tool for routine pharmaceutical QC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaceutical Analytical Chemistry, CIRM, ScF-Santé hub, University of Liège (ULiège), Liège, Belgium.
- Laboratory for the Analysis of Medicines, CIRM, University of Liège (ULiège), Liège, Belgium.
- Department of Analytical Chemistry, Nutrition and Food Sciences, Research Institute on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
ORCID-Profile: Hugues Jambo, Amandine Dispas, Éric Ziemons
Zitieren
APA
Jambo, H., Dispas, A., Pérez-Mayán, L., Rodríguez, I., Ziemons, É., & Hubert, P. (2024). Comprehensive analysis of vitamin D 3 impurities in oily drug products using supercritical fluid chromatography–mass spectrometry. Drug Testing and Analysis. https://doi.org/10.1002/dta.3670
Vancouver
Jambo H, Dispas A, Pérez-Mayán L, Rodríguez I, Ziemons É, Hubert P. Comprehensive analysis of vitamin D 3 impurities in oily drug products using supercritical fluid chromatography–mass spectrometry. Drug Testing and Analysis. 2024. doi:10.1002/dta.3670
BibTeX
@article{Jambo2024,
author = {Jambo, Hugues and Dispas, Amandine and Pérez-Mayán, Leticia and Rodríguez, Isaac and Ziemons, Éric and Hubert, Philippe},
title = {Comprehensive analysis of vitamin D 3 impurities in oily drug products using supercritical fluid chromatography–mass spectrometry},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3670}
}
EUVIMED